Vitamin A for Keratosis Pilaris

Vitamin A is essential for normal keratinisation, so true deficiency can cause follicular plugging like keratosis pilaris. But in replete people oral supplementation has no proven benefit and carries real toxicity risk; topical retinoids are the useful form.

Overview

Verdict

Insufficient evidence

How It Works

Vitamin A regulates proliferation and differentiation of keratinocytes. True deficiency produces follicular hyperkeratosis resembling keratosis pilaris. Topical retinoids normalise follicular keratinisation and are an evidence-based second-line treatment. Oral supplementation only helps where genuine deficiency exists.

Dosing & Protocol

Typical dose

Recommended dose: There is no evidence-based oral dose for keratosis pilaris in replete people, and self-supplementing is not recommended. Where a clinician confirms deficiency, standard repletion doses apply under supervision. Prescribed topical tretinoin or adapalene is the appropriate vitamin A-derived approach.
Expected timeframe: Topical retinoids take 8-12 weeks to show texture improvement

Protocol

form: Not applicable
duration: Not applicable
co factor: Evidence is insufficient. Oral vitamin A has never been tested in a controlled trial for keratosis pilaris. The rationale comes from topical retinoids, and topical treatment is where the (still modest) evidence sits: urea or lactic acid creams for the roughness, and topical tretinoin or adapalene for the plugging. Keratosis pilaris is a benign, very common and often self-limiting condition.
titration: Not applicable
starting dose: Not applicable as an established treatment

Evidence

What the studies say

The link between vitamin A deficiency and follicular hyperkeratosis is well established, but true deficiency is rare in developed countries. No controlled trials show oral vitamin A improves keratosis pilaris in people with normal status. Topical retinoids have better evidence, but that reflects drug action at the follicle, not nutritional supplementation.

Phrynoderma and acquired acrodermatitis enteropathica in breastfeeding women after bariatric surgery

Score: 3/10

2015

case_study

n=2

Monshi B, et al.

Based on clinical and histopathological findings, decreased vitamin A (patient 1) and zinc levels (patient 2), we diagnosed phrynoderma and acquired acrodermatitis enteropathica, respectively.

View source

Safety

Caveats

This is a case where the supplement is more dangerous than the condition. Vitamin A is fat-soluble and accumulates: the tolerable upper intake level is 3000 mcg RAE (10,000 IU) per day of preformed retinol, and chronic excess causes liver damage, raised intracranial pressure, bone loss and hair loss. Critically, vitamin A is a proven teratogen - high-dose retinol causes severe birth defects, so it must be avoided by anyone who is or may become pregnant. It interacts with retinoid medications such as isotretinoin and acitretin, where combined intake risks toxicity, and with anticoagulants. Beta-carotene supplements raise lung cancer risk in smokers. Use moisturisers and keratolytics instead.

Less likely to help if

Everyone: no oral vitamin A responder group has been demonstrated for this outcome.

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.